SCAP and metabolic dysfunction-associated steatohepatitis: Kawamura, Matsushita, et al. (8) independently tested the effects of SCAP deletion on NASH progression in a second mouse model in which symptoms develop from a choline-deficient, l–amino acid–defined, high-fat diet (CDAHFD) ( 9).